Detection of Pulmonary Embolism With CECT
Phase 4
Completed
- Conditions
- Pulmonary Embolism
- Registration Number
- NCT00351754
- Lead Sponsor
- Bracco Diagnostics, Inc
- Brief Summary
To compare the vascular enhancement of the two contrast agents in pulmonary Multi-detector CTA
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
- Patients 18 yrs or older
- With suspected PE
- Referred for MDCTA of pulmonary arteries
- Signed informed consent
Exclusion Criteria
- Pregnant and lactating females
- History of hypersensitivity to iodinated contrast agents
- Hyperthyroidism or pheochromocytoma
- Severe CHF
- Renal impairment
- Weight greater than 300 lbs
- Pacemaker
- Swan Ganz catheter
- Defibrillator or other intrathoracic metallic vascular device
- Received an investigational compound within 30 days of being in the study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Hounsfield Units (HU) measured at various levels of pulmonary arteries
- Secondary Outcome Measures
Name Time Method Presence of artifacts; global enhancement
Trial Locations
- Locations (1)
Bracco Diagnostics, Inc.
🇺🇸Princeton, New Jersey, United States